AUTS2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.836600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.477580E-02
Normal-vs-Stage2
3.302000E-01
Normal-vs-Stage3
4.871800E-02
Normal-vs-Stage4
4.464800E-01
Stage1-vs-Stage2
3.083000E-01
Stage1-vs-Stage3
5.507000E-01
Stage1-vs-Stage4
4.469600E-01
Stage2-vs-Stage3
2.063000E-01
Stage2-vs-Stage4
9.710800E-01
Stage3-vs-Stage4
3.890400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.740400E-01
Normal-vs-AfricanAmerican
9.457200E-01
Normal-vs-Asian
2.919600E-01
Caucasian-vs-AfricanAmerican
1.857610E-01
Caucasian-vs-Asian
6.842800E-01
AfricanAmerican-vs-Asian
3.182400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.852000E-01
Normal-vs-Female
2.998800E-01
Male-vs-Female
9.005800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.554100E-02
Normal-vs-Age(41-60Yrs)
6.195000E-01
Normal-vs-Age(61-80Yrs)
1.903440E-01
Normal-vs-Age(81-100Yrs)
1.259600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.943170E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.159800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.464600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.824700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.075800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.813000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.343400E-01
Normal-vs-Daily Drinker
4.042800E-01
Normal-vs-Weekly Drinker
4.170600E-01
Normal-vs-Occasional Drinker
3.989200E-01
Normal-vs-Social Drinker
7.341200E-01
Non Drinker-vs-Daily Drinker
8.663600E-01
Non Drinker-vs-Weekly Drinker
7.173800E-01
Non Drinker-vs-Occasional Drinker
7.915600E-01
Non Drinker-vs-Social Drinker
3.348200E-01
Daily Drinker-vs-Weekly Drinker
8.467800E-01
Daily Drinker-vs-Occasional Drinker
9.265200E-01
Daily Drinker-vs-Social Drinker
4.523800E-01
Weekly Drinker-vs-Occasional Drinker
9.140400E-01
Weekly Drinker-vs-Social Drinker
5.922000E-01
Occasional Drinker-vs-Social Drinker
5.072600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.451600E-01
Normal-vs-Grade 2
5.335600E-01
Normal-vs-Grade 3
5.346800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.812200E-01
Grade 1-vs-Grade 3
2.555400E-01
Grade 1-vs-Grade 4
7.451600E-01
Grade 2-vs-Grade 3
7.788200E-01
Grade 2-vs-Grade 4
5.335600E-01
Grade 3-vs-Grade 4
5.346800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.541600E-01
Normal-vs-NonDiabetic
3.483000E-01
Diabetic-vs-NonDiabetic
7.722400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.519400E-01
Normal-vs-NoPancreatitis
2.615200E-01
Pancreatitis-vs-NoPancreatitis
1.873210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.680400E-01
Normal-vs-N1
2.881800E-01
N0-vs-N1
6.834200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.050400E-01
Normal-vs-TP53-NonMutant
1.908250E-01
TP53-Mutant-vs-TP53-NonMutant
7.585800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
